Clinical Trial Update: Safety Study of Ch-mAb7F9 for Methamphetamine Abuse [Phase 1]

View source ↗

Summary

Phase 1 safety study of Ch-mAb7F9 for methamphetamine use disorder has completed, reporting safety data from an early-stage trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• Ch-mAb7F9 (Chimeric anti-methamphetamine monoclonal antibody)

Snippet

Sponsor: InterveXion Therapeutics, LLC | Conditions: Methamphetamine Abuse | Phase 1 | Status: COMPLETED